You are here

WCLC

WCLC: AstraZeneca's detailed Imfinzi, tremelimumab data in metastatic NSCLC are far from a clear-cut win

Fierce Pharma

Fri, 09/10/21 - 11:05 am

metastatic non-small cell lung cancer

WCLC: With Keytruda-Yervoy data, Merck casts doubt on Opdivo's place in lung cancer

Fierce Pharma

Sat, 01/30/21 - 11:32 pm

Bristol-Myers Squibb

WCLC: AstraZeneca builds case for growing ADC pipeline with double wins in advanced lung cancer

Endpoints

Fri, 01/29/21 - 10:03 am

antibody-drug conjugate

datopotomab deruxtecan

Bristol Myers' Opdivo-Yervoy duo slashes mesothelioma death risk by 26%

Fierce Pharma

Sat, 08/8/20 - 10:46 pm

Bristol-Myers Squibb

clinical trials

WCLC: Merck's Keytruda dispels 'urban legend' with latest lung cancer survival win

Fierce Pharma

Tue, 09/10/19 - 09:30 am

non-small cell lung cancer

At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More

Xconomy

Mon, 09/9/19 - 08:08 pm

Blueprint Medicines